Engaging in data sharing, observational cohort research, and deeper analysis of available data to yield further insights can drive improved results for patients, making label and cohort extension faster and more robust.
The post How Real-World Data Can Support Label Extension And Safer Use Of Novel Therapies appeared first on MedCity News.
